IMP
Process View
positive regulation of endothelial cell migration
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of endothelial cell migration"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGFR | epidermal growth factor receptor | 1.000 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | Human | |
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 1.000 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 1.000 | ||
| TEK | TEK tyrosine kinase, endothelial | 1.000 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 1.000 | ||
| LAT | linker for activation of T cells | 1.000 | ||
| PLCG1 | phospholipase C, gamma 1 | 1.000 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 1.000 | Human | |
| FGFR2 | fibroblast growth factor receptor 2 | 0.999 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.998 | ||
| VEGFA | vascular endothelial growth factor A | 0.998 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.997 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.988 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.987 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.985 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.985 | ||
| FN1 | fibronectin 1 | 0.984 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.979 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.975 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.974 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.973 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.967 | ||
| NRP1 | neuropilin 1 | 0.966 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.956 | Human | |
| YAP1 | Yes-associated protein 1 | 0.940 | ||
| SKIL | SKI-like oncogene | 0.936 | ||
| SYK | spleen tyrosine kinase | 0.929 | Zebrafish | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.919 | Human | |
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.907 | ||
| ENG | endoglin | 0.905 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.901 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.898 | ||
| FGA | fibrinogen alpha chain | 0.862 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.851 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.829 | ||
| FSTL1 | follistatin-like 1 | 0.818 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.810 | ||
| HSPB8 | heat shock 22kDa protein 8 | 0.788 | Human | |
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.752 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.749 | Human | |
| PPL | periplakin | 0.717 | ||
| SFN | stratifin | 0.667 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.653 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.638 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.540 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.534 | Human | |
| SMAD3 | SMAD family member 3 | 0.528 | ||
| PDGFC | platelet derived growth factor C | 0.504 | ||
| ANGPT2 | angiopoietin 2 | 0.498 | Human | |
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.462 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.436 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.430 | ||
| THBS1 | thrombospondin 1 | 0.420 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.417 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.411 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.409 | Human | |
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.409 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.406 | ||
| IRS1 | insulin receptor substrate 1 | 0.405 | ||
| TLN1 | talin 1 | 0.397 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.397 | ||
| SMAD2 | SMAD family member 2 | 0.384 | ||
| ITGB5 | integrin, beta 5 | 0.384 | ||
| AMOTL1 | angiomotin like 1 | 0.383 | Human Mouse | |
| RUNX1 | runt-related transcription factor 1 | 0.376 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.369 | ||
| AMOT | angiomotin | 0.339 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.333 | ||
| SMAD7 | SMAD family member 7 | 0.319 | ||
| FGF10 | fibroblast growth factor 10 | 0.317 | Human | |
| HSPB1 | heat shock 27kDa protein 1 | 0.315 | ||
| HDAC7 | histone deacetylase 7 | 0.315 | ||
| MUC1 | mucin 1, cell surface associated | 0.314 | ||
| MEF2C | myocyte enhancer factor 2C | 0.311 | ||
| HSPB7 | heat shock 27kDa protein family, member 7 (cardiovascular) | 0.310 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.305 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.299 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.293 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.275 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.256 | ||
| BMP2 | bone morphogenetic protein 2 | 0.255 | Human | |
| RFWD2 | ring finger and WD repeat domain 2 | 0.254 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.253 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.241 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.239 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.235 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.223 | ||
| AXL | AXL receptor tyrosine kinase | 0.222 | Human | |
| MPDZ | multiple PDZ domain protein | 0.214 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.207 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.206 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.196 | Human | |
| FZD1 | frizzled homolog 1 (Drosophila) | 0.193 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.183 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.181 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.177 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.174 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.173 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.173 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.169 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.165 | ||
| SNX9 | sorting nexin 9 | 0.161 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.158 | ||
| GAS6 | growth arrest-specific 6 | 0.153 | ||
| BMP4 | bone morphogenetic protein 4 | 0.151 | ||
| PRKD2 | protein kinase D2 | 0.151 | ||
| PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 0.144 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.144 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.144 | ||
| TWIST2 | twist homolog 2 (Drosophila) | 0.141 | ||
| VIM | vimentin | 0.137 | ||
| PRKCD | protein kinase C, delta | 0.135 | Human | |
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.133 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.131 | ||
| ACVR1 | activin A receptor, type I | 0.130 | Human | |
| ANGPT1 | angiopoietin 1 | 0.129 | ||
| TBX5 | T-box 5 | 0.126 | ||
| ANXA1 | annexin A1 | 0.126 | Human | |
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.123 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.123 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.122 | ||
| CRYAB | crystallin, alpha B | 0.117 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.116 | Human | |
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.115 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.115 | ||
| FGF7 | fibroblast growth factor 7 | 0.114 | Human | |
| JAK2 | Janus kinase 2 | 0.114 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.114 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.113 | ||
| MEF2A | myocyte enhancer factor 2A | 0.111 | ||
| SPRR2A | small proline-rich protein 2A | 0.111 | ||
| CTGF | connective tissue growth factor | 0.110 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.110 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.108 | Human | |
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.108 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.106 | Human | |
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.106 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.101 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.100 | ||
| PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.100 | ||
| SLA | Src-like-adaptor | 0.099 | ||
| JUN | jun proto-oncogene | 0.098 | ||
| CD34 | CD34 molecule | 0.096 | ||
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.095 | ||
| APP | amyloid beta (A4) precursor protein | 0.095 | ||
| CDCP1 | CUB domain containing protein 1 | 0.094 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.093 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.092 | ||
| GDF9 | growth differentiation factor 9 | 0.091 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.087 | ||
| PRKCA | protein kinase C, alpha | 0.084 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.084 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.082 | ||
| RXRA | retinoid X receptor, alpha | 0.081 | ||
| CAV2 | caveolin 2 | 0.079 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.078 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.075 | ||
| FHL2 | four and a half LIM domains 2 | 0.075 | ||
| PRKCB | protein kinase C, beta | 0.075 | Human | |
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.074 | ||
| ANXA2 | annexin A2 | 0.074 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.074 | ||
| PGF | placental growth factor | 0.072 | Human | |
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.071 | ||
| KRT18 | keratin 18 | 0.070 | ||
| MAPT | microtubule-associated protein tau | 0.069 | ||
| RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.069 | ||
| STAB1 | stabilin 1 | 0.068 | ||
| KRT8 | keratin 8 | 0.067 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.067 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.065 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.064 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.064 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.063 | ||
| SNRNP70 | small nuclear ribonucleoprotein 70kDa (U1) | 0.063 | ||
| SQSTM1 | sequestosome 1 | 0.063 | ||
| DCN | decorin | 0.062 | ||
| RARA | retinoic acid receptor, alpha | 0.062 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.061 | ||
| KLF13 | Kruppel-like factor 13 | 0.061 | ||
| CD247 | CD247 molecule | 0.061 | ||
| SH2D3C | SH2 domain containing 3C | 0.061 | ||
| ABL2 | v-abl Abelson murine leukemia viral oncogene homolog 2 | 0.061 | ||
| VWF | von Willebrand factor | 0.059 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.058 | Human | |
| PDCD6IP | programmed cell death 6 interacting protein | 0.058 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.057 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.057 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.056 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.056 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.056 | ||
| HSPA1B | heat shock 70kDa protein 1B | 0.055 | ||
| JAG1 | jagged 1 | 0.055 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.055 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.054 | ||
| KITLG | KIT ligand | 0.053 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.053 | ||
| CD63 | CD63 molecule | 0.052 | ||
| TBL1XR1 | transducin (beta)-like 1 X-linked receptor 1 | 0.052 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.051 | ||
| CALD1 | caldesmon 1 | 0.051 | ||
| PDCD6 | programmed cell death 6 | 0.051 | ||
| SMAD1 | SMAD family member 1 | 0.050 | ||
| INSR | insulin receptor | 0.050 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.050 | Human | |
| NCF2 | neutrophil cytosolic factor 2 | 0.050 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.050 | ||
| ACTB | actin, beta | 0.050 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.049 | ||
| LATS1 | LATS, large tumor suppressor, homolog 1 (Drosophila) | 0.049 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.048 | ||
| DAXX | death-domain associated protein | 0.048 | ||
| SH2D3A | SH2 domain containing 3A | 0.047 | ||
| DAPK1 | death-associated protein kinase 1 | 0.047 | ||
| TSC22D4 | TSC22 domain family, member 4 | 0.047 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.046 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.046 | ||
| AR | androgen receptor | 0.046 | ||
| APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 | 0.046 | ||
| INADL | InaD-like (Drosophila) | 0.046 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.045 | ||
| VAV2 | vav 2 guanine nucleotide exchange factor | 0.044 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.044 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.044 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.044 | ||
| NID1 | nidogen 1 | 0.042 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.042 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.042 | ||
| PML | promyelocytic leukemia | 0.042 | ||
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.042 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.041 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.041 | ||
| HSPB6 | heat shock protein, alpha-crystallin-related, B6 | 0.041 | Human | |
| HSF1 | heat shock transcription factor 1 | 0.040 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.040 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.040 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.039 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.038 | ||
| RBPMS | RNA binding protein with multiple splicing | 0.038 | ||
| MED28 | mediator complex subunit 28 | 0.038 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.037 | ||
| AHNAK | AHNAK nucleoprotein | 0.037 | ||
| CSF1R | colony stimulating factor 1 receptor | 0.035 | Human | |
| PLXNB1 | plexin B1 | 0.034 | ||
| PRKCI | protein kinase C, iota | 0.034 | Human | |
| VEGFC | vascular endothelial growth factor C | 0.034 | Human Rat | |
| SDC2 | syndecan 2 | 0.034 | ||
| ITGA6 | integrin, alpha 6 | 0.033 | ||
| CREBBP | CREB binding protein | 0.033 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.033 | ||
| VCAN | versican | 0.032 | ||
| ANXA5 | annexin A5 | 0.032 | Human | |
| NRP2 | neuropilin 2 | 0.032 | ||
| SPARCL1 | SPARC-like 1 (hevin) | 0.032 | Human | |
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.032 | ||
| GHR | growth hormone receptor | 0.032 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.032 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.031 | ||
| STX5 | syntaxin 5 | 0.031 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.031 | ||
| SMAD6 | SMAD family member 6 | 0.030 | ||
| PLXDC1 | plexin domain containing 1 | 0.030 | ||
| DLC1 | deleted in liver cancer 1 | 0.030 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.030 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.029 | ||
| FLNA | filamin A, alpha | 0.029 | ||
| FGG | fibrinogen gamma chain | 0.029 | ||
| TNS4 | tensin 4 | 0.029 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.028 | ||
| AES | amino-terminal enhancer of split | 0.028 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.028 | ||
| CD248 | CD248 molecule, endosialin | 0.028 | ||
| NOTCH4 | notch 4 | 0.028 | ||
| APOA1 | apolipoprotein A-I | 0.028 | ||
| FBLN1 | fibulin 1 | 0.028 | ||
| CD93 | CD93 molecule | 0.027 | ||
| RRBP1 | ribosome binding protein 1 homolog 180kDa (dog) | 0.027 | ||
| CMTM8 | CKLF-like MARVEL transmembrane domain containing 8 | 0.027 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.027 | ||
| TRIM9 | tripartite motif containing 9 | 0.027 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.027 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.027 | ||
| LRRC17 | leucine rich repeat containing 17 | 0.027 | ||
| SSR1 | signal sequence receptor, alpha | 0.027 | ||
| ANXA4 | annexin A4 | 0.027 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.027 | ||
| ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 0.027 | ||
| TPM2 | tropomyosin 2 (beta) | 0.027 | ||
| ZBTB16 | zinc finger and BTB domain containing 16 | 0.027 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.027 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.026 | ||
| RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.026 | ||
| DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | 0.026 | ||
| EPHB1 | EPH receptor B1 | 0.026 | ||
| LDLR | low density lipoprotein receptor | 0.026 | ||
| SOS2 | son of sevenless homolog 2 (Drosophila) | 0.026 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.026 | ||
| STC1 | stanniocalcin 1 | 0.026 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.025 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.025 | ||
| PARVA | parvin, alpha | 0.025 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.025 | ||
| CXXC5 | CXXC finger protein 5 | 0.025 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.025 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.025 | ||
| FLNB | filamin B, beta | 0.025 | ||
| SETDB1 | SET domain, bifurcated 1 | 0.025 | ||
| HDAC6 | histone deacetylase 6 | 0.025 | ||
| BGN | biglycan | 0.024 | ||
| EGF | epidermal growth factor | 0.024 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.024 | ||
| AKAP2 | A kinase (PRKA) anchor protein 2 | 0.024 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.024 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.024 | ||
| VCL | vinculin | 0.024 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.024 | ||
| PTPRM | protein tyrosine phosphatase, receptor type, M | 0.024 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.024 | ||
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.023 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.023 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.023 | ||
| AQP1 | aquaporin 1 (Colton blood group) | 0.023 | ||
| BAD | BCL2-associated agonist of cell death | 0.023 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.023 | ||
| AMOTL2 | angiomotin like 2 | 0.023 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.023 | ||
| BAG6 | BCL2-associated athanogene 6 | 0.023 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.023 | ||
| PMP22 | peripheral myelin protein 22 | 0.023 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.023 | ||
| PTRF | polymerase I and transcript release factor | 0.023 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.022 | ||
| ADAM9 | ADAM metallopeptidase domain 9 | 0.022 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.022 | ||
| LAMB1 | laminin, beta 1 | 0.022 | ||
| TRIB3 | tribbles homolog 3 (Drosophila) | 0.022 | ||
| ARHGEF10L | Rho guanine nucleotide exchange factor (GEF) 10-like | 0.022 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.022 | ||
| RGL1 | ral guanine nucleotide dissociation stimulator-like 1 | 0.022 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.022 | ||
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.022 | ||
| SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.022 | ||
| INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.022 | ||
| S1PR1 | sphingosine-1-phosphate receptor 1 | 0.022 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.022 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.022 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.021 | ||
| JAM2 | junctional adhesion molecule 2 | 0.021 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.021 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.021 | ||
| DCTN1 | dynactin 1 | 0.021 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.021 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.021 | ||
| CHMP4B | chromatin modifying protein 4B | 0.021 | ||
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.021 | ||
| TBX2 | T-box 2 | 0.021 | ||
| CLIC4 | chloride intracellular channel 4 | 0.021 | ||
| EDN1 | endothelin 1 | 0.021 | ||
| NDUFA4L2 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 | 0.021 | ||
| FOXP3 | forkhead box P3 | 0.020 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.020 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.020 | ||
| HEG1 | HEG homolog 1 (zebrafish) | 0.020 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.020 | ||
| DKK3 | dickkopf homolog 3 (Xenopus laevis) | 0.020 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.020 | ||
| TEAD1 | TEA domain family member 1 (SV40 transcriptional enhancer factor) | 0.020 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.020 | ||
| SLIT3 | slit homolog 3 (Drosophila) | 0.019 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.019 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.019 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.019 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.019 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.019 | ||
| RIN3 | Ras and Rab interactor 3 | 0.019 | ||
| HDAC3 | histone deacetylase 3 | 0.019 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.019 | ||
| ARHGAP32 | Rho GTPase activating protein 32 | 0.019 | ||
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.019 | ||
| PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.019 | ||
| THBD | thrombomodulin | 0.019 | ||
| SASH1 | SAM and SH3 domain containing 1 | 0.019 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.019 | ||
| BLK | B lymphoid tyrosine kinase | 0.019 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.019 | ||
| MSN | moesin | 0.018 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.018 | ||
| CTTN | cortactin | 0.018 | ||
| FZD2 | frizzled homolog 2 (Drosophila) | 0.018 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.018 | ||
| FERMT2 | fermitin family member 2 | 0.018 | ||
| WWTR1 | WW domain containing transcription regulator 1 | 0.018 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.018 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.018 | ||
| SPON1 | spondin 1, extracellular matrix protein | 0.018 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.018 | ||
| DOK4 | docking protein 4 | 0.018 | ||
| SHB | Src homology 2 domain containing adaptor protein B | 0.018 | ||
| ZFPM1 | zinc finger protein, multitype 1 | 0.018 | ||
| CD9 | CD9 molecule | 0.018 | ||
| SESN2 | sestrin 2 | 0.018 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.018 | ||
| ITGB4 | integrin, beta 4 | 0.018 | ||
| ACVR1B | activin A receptor, type IB | 0.018 | Human | |
| PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 0.018 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.017 | ||
| LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.017 | ||
| EPOR | erythropoietin receptor | 0.017 | ||
| RET | ret proto-oncogene | 0.017 | ||
| IPO11 | importin 11 | 0.017 | ||
| GUCY1A3 | guanylate cyclase 1, soluble, alpha 3 | 0.017 | ||
| SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.017 | ||
| EPHA2 | EPH receptor A2 | 0.017 | ||
| FBN1 | fibrillin 1 | 0.017 | ||
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.017 | ||
| CMIP | c-Maf-inducing protein | 0.017 | ||
| CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 0.017 | ||
| EMCN | endomucin | 0.017 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.017 | ||
| FRZB | frizzled-related protein | 0.017 | ||
| OSMR | oncostatin M receptor | 0.017 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.017 | ||
| MAP2 | microtubule-associated protein 2 | 0.017 | ||
| MLL4 | myeloid/lymphoid or mixed-lineage leukemia 4 | 0.016 | ||
| INHBB | inhibin, beta B | 0.016 | ||
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.016 | ||
| LDB2 | LIM domain binding 2 | 0.016 | ||
| SH2D2A | SH2 domain containing 2A | 0.016 | ||
| OGN | osteoglycin | 0.016 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.016 | ||
| MEIS1 | Meis homeobox 1 | 0.016 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.016 | ||
| ZCCHC24 | zinc finger, CCHC domain containing 24 | 0.016 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.016 | ||
| LPAR1 | lysophosphatidic acid receptor 1 | 0.016 | ||
| PTPRE | protein tyrosine phosphatase, receptor type, E | 0.016 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.016 | ||
| ANXA11 | annexin A11 | 0.016 | Human | |
| EDNRB | endothelin receptor type B | 0.015 | ||
| DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.015 | ||
| RIN2 | Ras and Rab interactor 2 | 0.015 | ||
| AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0.015 | Human | |
| SHANK3 | SH3 and multiple ankyrin repeat domains 3 | 0.015 | ||
| DGKA | diacylglycerol kinase, alpha 80kDa | 0.015 | ||
| PKP3 | plakophilin 3 | 0.015 | ||
| EZR | ezrin | 0.015 | ||
| MGP | matrix Gla protein | 0.015 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.015 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.015 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.015 | ||
| AEBP1 | AE binding protein 1 | 0.015 | ||
| CD33 | CD33 molecule | 0.015 | ||
| RECK | reversion-inducing-cysteine-rich protein with kazal motifs | 0.015 | ||
| ARHGAP21 | Rho GTPase activating protein 21 | 0.015 | ||
| CISH | cytokine inducible SH2-containing protein | 0.015 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.015 | ||
| MYO10 | myosin X | 0.015 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.015 | ||
| TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.015 | ||
| GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 0.015 | ||
| GPC3 | glypican 3 | 0.015 | ||
| TNS3 | tensin 3 | 0.015 | ||
| MAPK1IP1L | mitogen-activated protein kinase 1 interacting protein 1-like | 0.015 | ||
| MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.015 | ||
| LAPTM4A | lysosomal protein transmembrane 4 alpha | 0.015 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.015 | ||
| A2M | alpha-2-macroglobulin | 0.015 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.015 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.015 | ||
| PCDH9 | protocadherin 9 | 0.015 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.015 | ||
| FGF4 | fibroblast growth factor 4 | 0.014 | Human | |
| TLR3 | toll-like receptor 3 | 0.014 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.014 | ||
| SAMD4B | sterile alpha motif domain containing 4B | 0.014 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.014 | ||
| KIAA1462 | KIAA1462 | 0.014 | ||
| PPP1R14A | protein phosphatase 1, regulatory (inhibitor) subunit 14A | 0.014 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.014 | ||
| ACVR2B | activin A receptor, type IIB | 0.014 | ||
| ZNF512B | zinc finger protein 512B | 0.014 | ||
| TWSG1 | twisted gastrulation homolog 1 (Drosophila) | 0.014 | ||
| GIMAP6 | GTPase, IMAP family member 6 | 0.014 | ||
| TGFA | transforming growth factor, alpha | 0.014 | ||
| TP73 | tumor protein p73 | 0.014 | ||
| TCF4 | transcription factor 4 | 0.014 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.014 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.014 | ||
| ANKS1A | ankyrin repeat and sterile alpha motif domain containing 1A | 0.014 | ||
| PGCP | plasma glutamate carboxypeptidase | 0.014 | ||
| KRT5 | keratin 5 | 0.014 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.014 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.014 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.014 | ||
| DLGAP3 | discs, large (Drosophila) homolog-associated protein 3 | 0.014 | ||
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.014 | ||
| HDAC9 | histone deacetylase 9 | 0.014 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.014 | ||
| GPR116 | G protein-coupled receptor 116 | 0.014 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.014 | ||
| MED25 | mediator complex subunit 25 | 0.014 | ||
| SSPN | sarcospan (Kras oncogene-associated gene) | 0.014 | ||
| OLFML1 | olfactomedin-like 1 | 0.013 | ||
| ETV1 | ets variant 1 | 0.013 | Human | |
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.013 | ||
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 0.013 | ||
| PIK3CD | phosphoinositide-3-kinase, catalytic, delta polypeptide | 0.013 | ||
| SERPINE2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 | 0.013 | ||
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.013 | ||
| PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.013 | Human | |
| ELANE | elastase, neutrophil expressed | 0.013 | ||
| BCAR3 | breast cancer anti-estrogen resistance 3 | 0.013 | ||
| MCAM | melanoma cell adhesion molecule | 0.013 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.013 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.013 | ||
| PLAT | plasminogen activator, tissue | 0.013 | ||
| WNT3 | wingless-type MMTV integration site family, member 3 | 0.013 | ||
| BLNK | B-cell linker | 0.013 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.013 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.013 | ||
| MMRN2 | multimerin 2 | 0.013 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.013 | ||
| CD59 | CD59 molecule, complement regulatory protein | 0.013 | ||
| DOK6 | docking protein 6 | 0.013 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.013 | ||
| THY1 | Thy-1 cell surface antigen | 0.013 | ||
| SOX13 | SRY (sex determining region Y)-box 13 | 0.013 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.013 | Human | |
| TRIL | TLR4 interactor with leucine-rich repeats | 0.013 | ||
| LRRC8C | leucine rich repeat containing 8 family, member C | 0.013 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.013 | ||
| NUAK1 | NUAK family, SNF1-like kinase, 1 | 0.013 | ||
| THSD7A | thrombospondin, type I, domain containing 7A | 0.013 | ||
| PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.013 | ||
| HOXB5 | homeobox B5 | 0.012 | ||
| ILK | integrin-linked kinase | 0.012 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.012 | ||
| LRMP | lymphoid-restricted membrane protein | 0.012 | ||
| PRKCQ | protein kinase C, theta | 0.012 | Human | |
| DUSP1 | dual specificity phosphatase 1 | 0.012 | ||
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0.012 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.012 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.012 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.012 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.012 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.012 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.012 | ||
| ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | 0.012 | ||
| GATA2 | GATA binding protein 2 | 0.012 | Human | |
| FGF3 | fibroblast growth factor 3 | 0.012 | ||
| HTRA1 | HtrA serine peptidase 1 | 0.012 | ||
| PNMA1 | paraneoplastic antigen MA1 | 0.012 | ||
| EXT1 | exostosin 1 | 0.012 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.012 | ||
| PALLD | palladin, cytoskeletal associated protein | 0.012 | ||
| MYOF | myoferlin | 0.012 | ||
| HEBP2 | heme binding protein 2 | 0.012 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.012 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.012 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.012 | ||
| ZEB1 | zinc finger E-box binding homeobox 1 | 0.012 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.012 | Human | |
| CD4 | CD4 molecule | 0.012 | ||
| GPC1 | glypican 1 | 0.012 | ||
| THBS2 | thrombospondin 2 | 0.012 | Human | |
| IGFBP7 | insulin-like growth factor binding protein 7 | 0.012 | ||
| IRS4 | insulin receptor substrate 4 | 0.012 | ||
| AHR | aryl hydrocarbon receptor | 0.012 | ||
| PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 0.012 | ||
| HNF1B | HNF1 homeobox B | 0.012 | ||
| EFNA1 | ephrin-A1 | 0.012 | ||
| NRG1 | neuregulin 1 | 0.012 | ||
| BCL6B | B-cell CLL/lymphoma 6, member B | 0.012 | ||
| ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 | 0.011 | ||
| CCHCR1 | coiled-coil alpha-helical rod protein 1 | 0.011 | ||
| SEPT11 | septin 11 | 0.011 | ||
| HAND2 | heart and neural crest derivatives expressed 2 | 0.011 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.011 | ||
| TBL1X | transducin (beta)-like 1X-linked | 0.011 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.011 | ||
| CALCRL | calcitonin receptor-like | 0.011 | ||
| YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.011 | ||
| SGCD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) | 0.011 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.011 | ||
| PDK4 | pyruvate dehydrogenase kinase, isozyme 4 | 0.011 | ||
| CCDC50 | coiled-coil domain containing 50 | 0.011 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.011 | ||
| MAP3K12 | mitogen-activated protein kinase kinase kinase 12 | 0.011 | ||
| GPM6B | glycoprotein M6B | 0.011 | ||
| RUNX2 | runt-related transcription factor 2 | 0.011 | ||
| BDNF | brain-derived neurotrophic factor | 0.011 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.011 | ||
| MAPK10 | mitogen-activated protein kinase 10 | 0.011 | ||
| TBX3 | T-box 3 | 0.011 | ||
| ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 0.011 | ||
| C13orf15 | chromosome 13 open reading frame 15 | 0.011 | ||
| FLI1 | Friend leukemia virus integration 1 | 0.011 | ||
| MN1 | meningioma (disrupted in balanced translocation) 1 | 0.011 | ||
| ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | 0.011 | ||
| NF2 | neurofibromin 2 (merlin) | 0.011 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.011 | ||
| GJA5 | gap junction protein, alpha 5, 40kDa | 0.011 | ||
| CBFA2T3 | core-binding factor, runt domain, alpha subunit 2; translocated to, 3 | 0.011 | ||
| EMP1 | epithelial membrane protein 1 | 0.011 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.011 | ||
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.011 | ||
| PRSS23 | protease, serine, 23 | 0.011 | ||
| CX3CR1 | chemokine (C-X3-C motif) receptor 1 | 0.011 | ||
| RARG | retinoic acid receptor, gamma | 0.011 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.011 | ||
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.011 | ||
| GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.011 | Human | |
| BMP6 | bone morphogenetic protein 6 | 0.011 | ||
| CLNK | cytokine-dependent hematopoietic cell linker | 0.010 | ||
| POFUT1 | protein O-fucosyltransferase 1 | 0.010 | ||
| BMX | BMX non-receptor tyrosine kinase | 0.010 | ||
| ETV6 | ets variant 6 | 0.010 | ||
| PTK6 | PTK6 protein tyrosine kinase 6 | 0.010 | ||
| PTPRG | protein tyrosine phosphatase, receptor type, G | 0.010 | ||
| MECOM | MDS1 and EVI1 complex locus | 0.010 | ||
| HOXA11 | homeobox A11 | 0.010 | ||
| TPM1 | tropomyosin 1 (alpha) | 0.010 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.010 | ||
| FKBP10 | FK506 binding protein 10, 65 kDa | 0.010 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.010 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.010 | ||
| HSPA1A | heat shock 70kDa protein 1A | 0.010 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.010 | ||
| S100A10 | S100 calcium binding protein A10 | 0.010 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.010 | ||
| FOXF1 | forkhead box F1 | 0.010 | ||
| FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0.010 | Human | |
| TMEM100 | transmembrane protein 100 | 0.010 | ||
| RARB | retinoic acid receptor, beta | 0.010 | ||
| WWC1 | WW and C2 domain containing 1 | 0.010 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.010 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.010 | ||
| GPC4 | glypican 4 | 0.010 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.010 | ||
| OLFML3 | olfactomedin-like 3 | 0.010 | ||
| CCDC92 | coiled-coil domain containing 92 | 0.010 |